FrancophonIA/ELRC3.0 huggingface dataset:
English: For ducks the recommended dosage is 17.4 mg amoxicillin (equivalent to 25 mg veterinary medicinal product) per kg body weight for 3 consecutive days.
Croatian: Preporučena doza za patke iznosi 17,4 mg amoksicilina (istovjetno 25 mg veterinarsko-medicinskog proizvoda) po kilogramu tjelesne težine tijekom 3 uzastopna dana.
English: Recommended dosage is 13.1-17.4 mg amoxicillin (equivalent to 18.8 to 25 mg veterinary medicinal product) per kg body weight for 3 days or in severe cases for 5 days.
Croatian: Preporučena doza je 13,1-17,4 mg amoksicilina (ekvivalentno 18,8 do 25 mg veterinarskomedicinskog proizvoda) po kg tjelesne težine tijekom 3 dana ili, u težim slučajevima, tijekom 5 dana.
English: The recommended dosage for chickens is 13.1 mg amoxicillin (equivalent to 18.8 mg veterinary medicinal product) per kg body weight for 3 days or in severe cases for 5 days.
Croatian: Preporučena doza za piliće iznosi 13,1 mg amoksicilina (istovjetno 18,8 mg veterinarsko-medicinskog proizvoda) po kilogramu tjelesne težine tijekom 3 dana ili, u teškim slučajevima, tijekom 5 dana.
English: The recommended dosage is 13.1 mg amoxicillin (equivalent to 18.8 mg veterinary medicinal product) per kg body weight for 3 days or in severe cases for 5 days.
Croatian: Preporučena doza je 13,1 mg amoksicilina (ekvivalentno 18,8 mg veterinarsko-medicinskog proizvoda) po kg tjelesne težine tijekom 3 dana ili, u težim slučajevima, tijekom 5 dana.
English: For turkeys the recommended dosage is 13.1-17.4 mg amoxicillin (equivalent to 18.8 to 25 mg veterinary medicinal product) per kg body weight for 3 days or in severe cases for 5 days.
Croatian: Preporučena doza za pure iznosi 13,1-17,4 mg amoksicilina (istovjetno 18,8 do 25 mg veterinarsko-medicinskog proizvoda) po kilogramu tjelesne težine tijekom 3 dana ili, u teškim slučajevima, tijekom 5 dana.
English: • The Committee considered the notification of the referral triggered by Germany under Article 29(4) of Directive 2001/83/EC.
Croatian: • je Odbor razmotrio obavijest o postupku upućivanja kojeg je pokrenula Njemačka u skladu sa člankom 29. stavkom 4. Direktive 2001/83/EZ.
English: Spain considered that the granting of the marketing authorisation constitutes a potential serious risk to public health.
Croatian: Španjolska je smatrala da izdavanje odobrenja za stavljanje lijeka u promet predstavlja potencijalan ozbiljan rizik za javno zdravstvo.
English: These results are supported by two other studies published by Ringe and Schacht (2012, 2013).
Croatian: Ovi su rezultati podržani dvama drugim ispitivanjima objavljenima od strane Ringe i Schacht (2012., 2013.).
English: Both active substances are currently authorised either as monotherapy or in association (combination pack).
Croatian: Obje djelatne tvari su trenutno odobrene kao monoterapija ili u kombinaciji (kombinirani paket).
English: However, the Committee considered that the statement on the reduction in the fall rate in the elderly should not be included in the indication.
Croatian: No, Odbor je smatrao da se izjava o smanjenju stope padova u starijih osoba ne treba uključiti u indikaciju.
English: Studies on physical performance and balance
Croatian: Ispitivanja fizičke učinkovitosti i ravnoteže
English: Hence, the treatment effect in a grouped meta-analysis, even with trials where ‘fallers' was not always the primary endpoint, remains significant independent of study design differences.
Croatian: Stoga, djelovanje liječenja u grupiranoj meta analizi, čak i u slučaju ispitivanja u slučaju koji „osobe koje padaju” nisu uvijek bila primarna završna točka, ostaje značajan nezavisna razlika u dizajnu.
English: The treatment effect was always significant when major reported trials were analysed together.
Croatian: Djelovanje liječenja smatralo se uvijek važnim prilikom zajedničke analize većih prijavljenih ispitivanja.
English: The decentralised procedure was closed on day 210, with most of the CMS agreeing with the conclusions of the reference member state except Spain which raised a potential serious risk to public health (PSRPH).
Croatian: Decentralizirani postupak zaključen je 210. dana tako što se većina CMS-ova složila sa zaključcima referentne države članice, uz iznimku Španjolske koja je istaknula potencijalan ozbiljan rizik za javno zdravstvo (PSRPH).
English: The package leaflet should be amended accordingly.
Croatian: Prema tome treba izmijeniti uputu o uporabi.
English: It is converted rapidly in the liver to 1,25 dihydroxyvitamin D, so called calcitriol.
Croatian: Brzo se konvertira u jetri u 1.25 dihidroksivitamin D, takozvani kalcitriol.
English: Population pharmacokinetic modelling and simulation at steady state
Croatian: Populacijsko farmakokinetičko modeliranje i simulacija u stabilnom stanju
English: The CHMP considered that the statement on falls should not be included in the section 4.1 of the SmPC.
Croatian: CHMP smatra da se izjava o padovima ne treba uključiti u dio 4.1 SPC-a.
English: The results showed a consistent odds ratio at around 0.65 in all analyses, suggesting a reliable estimated of treatment effect as compared to placebo.
Croatian: Rezultati su pokazali konzistentan omjer izgleda pri otprilike 0,65 u svim analizama, što ukazuje na pouzdanu procjenu djelovanja liječenja u usporedbi s placebom.
English: Bisphosphonates have strong pharmacodynamic action on osteoclast activity.
Croatian: Bisfosfonati imaju snažno farmakodinamičko djelovanje na aktivnost osteoklasta.
English: Overall summary of the scientific evaluation of Valebo and associated names (see Annex I)
Croatian: Cjelokupan sažetak znanstvene procjene lijeka Valebo i povezanih naziva (vidi Prilog I.)
English: In addition, the results of these studies, showing a significant reduction in fall-related non-vertebral fractures, have been confirmed by independent meta-analyses (Bischoff-Ferrari, 2004b6; BischoffFerrari, 20097; O'Donnell, 20088; Richy, 20089).
Croatian: Nadalje, rezultati ovih ispitivanja koji dokazuju značajno smanjenje u broju nevertebralnih prijeloma povezanih s padovima, potvrđeni su od strane nezavisnih meta analiza (Bischoff-Ferrari, 2004.b6; Bischoff-Ferrari, 2009.7; O'Donnell, 2008.8; Richy, 2008.9).
English: A post hoc analyses by medians of total calcium intake detected statistically significant differences.
Croatian: Post hoc analize provedene po medijanima ukupnog unosa kalcija otkrile su statistički značajne razlike.
English: • The Committee is of the opinion that, based on available results of clinical trials and metaanalyses, the efficacy of alfacalcidol in combination with alendronic acid has been adequately demonstrated.
Croatian: • je Odbor mišljenja da je, na temelju dostupnih rezultata kliničkih ispitivanja i meta analiza, djelotvornost alfakalcidola u kombinaciji s alendronatnom kiselinom odgovarajuće dokazana.
English: Valebo is a combination package consisting of tablets containing 70 mg of alendronate sodium (alendronic acid) and soft capsules containing 1µg of alfacalcidol.
Croatian: Valebo je kombinirani paket koji se sastoji od tableta koje sadrže 70 mg alendronat natrija (alendronatna kiselina) i meke kapsule koje sadrže 1µg alfakalcidola.
English: The open, multi-centre, prospective studies (Schacht and Ringe, 20121, Schacht and Ringe, 20112) demonstrated that treatment with alfacalcidol 1 μg resulted in significant increases in physical performance and balance in elderly women and men with and without an increased risk of falls as well as with and without Vitamin D insufficiency/deficiency.
Croatian: Otvorena, prospektivna ispitivanja (Schacht i Ringe, 2012.1, Schacht i Ringe, 2011.2) provedena u više centara dokazala su da je liječenje dozom alfakalcidola od 1 μg rezultiralo značajnim povećanjem u fizičkoj učinkovitosti i ravnoteži u starijih žena i muškaraca s i bez povećanog rizika od padova, kao i s i bez insuficijencije/deficijencije vitamina D.
English: • The Committee reviewed all the data submitted by the applicant in order to support the role of alfacalcidol in the reduction of the fall rate.
Croatian: • je Odbor pregledao sve podatke dostavljene od strane podnositelja zahtjeva kako bi podržalo ulogu alfakalcidola u smanjivanju stope padova.
English: Alfacalcidol is a vitamin D analogue which acts as a regulator of calcium and phosphate metabolism.
Croatian: Alfakalcidol je analog vitaminu D koji djeluje kao regulator metabolizma kalcija i fosfata.
English: the CHMP has recommended the granting of the marketing authorisations for which the summary of product characteristics, labelling and package leaflet remain as per the final versions achieved during the Coordination group procedure with the amendment as mentioned in Annex III for Valebo and associated names (see Annex I).
Croatian: CHMP je preporučio izdavanje odobrenja za stavljanje lijeka u promet za koje sažetak opisa svojstava lijeka, etiketa i uputa o lijeku ostaju jednaki konačnim verzijama usuglašenima tijekom postupka koordinacijske grupe s izmjenama navedenima u Prilogu III. za lijek Valebo i povezane nazive (vidi Prilog I.).
English: Dukas et al (2004) presented a randomised, double-blind, placebo controlled trial with ‘number of fallers' as primary endpoint and an adequate number of patients.
Croatian: Dukas et al (2004.) predstavili su randomizirano, dvostruko slijepo ispitivanje kontrolirano placebom s „brojem osoba koje padaju” kao primarnom završnom točkom i primjerenim brojem bolesnika.
English: The applicant claimed that alfacalcidol 1 μg daily and of calcitriol 0.25 μg twice a day are therapeutically equivalent, and therefore they considered that the results of this randomised clinical trial can be directly extrapolated to alfacalcidol.
Croatian: Podnositelj zahtjeva tvrdio je da su doza alfakalcidola od 1 μg dnevno i doza kalcitriola od 0,25 μg dva puta dnevno terapijski ekvivalenti, te stoga oni smatraju da se rezultati ovog randomiziranog kliničkog ispitivanja mogu ekstrapolirati na alfakalcidol.
English: Alfacalcidol is indicated in various conditions where there is a disturbance of calcium or phosphorus metabolism.
Croatian: Alfakalcidol indiciran je za različita stanja, u kojima postoji poremećaj metabolizma kalcija ili fosfora.
English: The CHMP was of the opinion that results with calcitriol could be used as supportive data but not to conclude about the role of alfacalcidol in fall rate without confirmatory studies with alfacalcidol.
Croatian: CHMP je bio mišljenja da se rezultati prikupljeni za kalcitriol mogu iskoristiti kao potporni podaci, no ne pružaju nikakve zaključke o ulozi alfakalcidola u stopi padova bez potvrdnih ispitivanja s alfakalcidolom.
English: To support the inclusion of this indication the application should be based on parallel-group, randomised, double-blind, placebo or comparator controlled clinical trials with an adequate number of patients.
Croatian: U prilog uključivanja ove indikacije, zahtjev se mora temeljiti na randomiziranim, dvostruko slijepim kliničkim ispitivanjima kontroliranima paralelnim grupama, placebom ili komparatorom s primjerenim brojem bolesnika.
English: The applicant performed a meta-analysis of the most relevant clinical studies (Gallagher, 2004; Dukas, 2004; Ringe, 201310 and Kaya, 201111) reporting the number of fallers following either alfacalcidol or calcitriol therapy.
Croatian: Podnositelj zahtjeva proveo je meta analizu najvažnijih kliničkih ispitivanja (Gallagher, 2004.; Dukas, 2004.; Ringe, 2013.10 i Kaya, 2011.11) koja su prijavila broj osoba koje padaju nakon terapije alfakalcidolom ili kalcitriolom.
English: Rheumatol Int 2013;33(3):637-43; Epub 2012 Apr 8.
Croatian: Rheumatol Int 2013;33(3):637-43; Epub 2012 Apr 8. 11 Kaya U et al.
English: Systemic levels are shown to be equivalent at steady state under scaled dosing and there is no significant difference in predicted AUC's (Area Under the Curve) at six months between alfacalcidol 1 μg once-aday (QD) and calcitriol 0.25 μg twice-daily (BID).
Croatian: Dokazano je da su sistemske razine ekvivalentne u stabilnom stanju pri skaliranom doziranju te da nema značajne razlike u predviđenom AUC-u (području ispod krivulje) u šest mjeseci između alfakalcidola od 1 μg jednom dnevno (QD) i kalcitriola od 0,25 μg dva puta dnevno (BID).
English: The major concern raised by Spain could not be solved during the CMDh referral and the issue was therefore referred to the CHMP.
Croatian: Najvažnije pitanje sigurne primjene, koje je istaknula Španjolska nije uspješno riješeno tijekom postupka upućivanja CMDh-u, te je stoga predmet upućen CHMP-u.
English: The proposed indication by the applicant for Valebo was the “Treatment of postmenopausal osteoporosis.
Croatian: Predložena indikacija od strane podnositelja zahtjeva za stavljanje u promet lijeka Valebo glasila je „liječenje postmenopauzane osteoporoze.
English: A referral was thus triggered at the CMDh.
Croatian: Stoga je započet postupak upućivanja CMDh-u.
English: During the decentralised procedure, concerned member states (CMS) expressed the opinion that the role of alfacalcidol in the reduction in the fall rate has not been demonstrated.
Croatian: Tijekom decentraliziranog postupka, zemlje članice sudionice u postupku (CMS) iznijele su svoja mišljenja da nije dokazana uloga alfakalcidola u stopi pada.
English: Alendronic acid is indicated in the treatment of postmenopausal osteoporosis (PMO).
Croatian: Alendronatna kiselina indicirana je za liječenje postmenopauzne osteoporoze (PMO-a).
English: Having considered that data submitted by the applicant, the CHMP considered that there is sufficient evidence to conclude that in some clinical studies, alfacalcidol has been shown to reduce the risk of falls in the elderly.
Croatian: Nakon razmatranja podataka koje je dostavio podnositelj zahtjeva, CHMP je zaključio da postoji dovoljno dokaza za donošenje zaključka kako je u pojedinim kliničkim ispitivanjima dokazano da alfakalcidol smanjuje rizik od padova u starijih osoba.
English: These studies demonstrated the efficacy of the vitamin D analogues alfacalcidol and calcitriol on falls in elderly men and women and in postmenopausal women without diagnosed vitamin D insufficiency.
Croatian: Ova su ispitivanja pokazala da djelotvornost analoga vitamina D, alfakalcidola i kalcitriola, za padove u starijih muškaraca i žena kao i u postmenopauzanih žena u kojih nije dijagnosticirana insuficijencija vitamina D.
English: Other studies had been performed to specifically investigate the efficacy and safety of alfacalcidol in monotherapy and combination therapy on the reduction of falls in elderly and patients with PMO (Dukas, 20043; Gallagher, 20044; Ringe, 20075).
Croatian: Druga su ispitivanja provedena kako bi se posebice istražila djelotvornost i sigurnost alfakalcidola u monoterapiji i kombiniranoj terapiji za smanjenje broja padova u starijih osoba i bolesnika koji boluju od PMO-a (Dukas, 2004.3; Gallagher, 2004.4; Ringe, 2007.5).
English: Alendronic acid reduces the risk of vertebral and hip fractures, whilst a significant reduction in the fall rate has been demonstrated for alfacalcidol in the elderly”.
Croatian: Alendronatna kiselina smanjuje rizik od vertebralnih prijeloma i prijeloma kuka, pri čemu je dokazano značajno smanjenje u stopi pada za alfakalcidol u starijih osoba”.
English: However, the CHMP agreed to provide the respective information in the section 5.1 of the SmPC “In some clinical studies, alfacalcidol has been shown to reduce the risk of falls in the elderly”.
Croatian: No, CHMP je suglasan da se odgovarajuće informacije navedu u dijelu 5.1 SPC-a „U pojedinim kliničkim ispitivanjima dokazano je da alfakalcidol smanjuje rizik od padova u starijih osoba”.
English: Gallagher et al (2004) examined the effects of calcitriol on falls in a randomised, double-blind, placebocontrolled study in 489 postmenopausal, Vitamin D replete/sufficient women with osteopenia.
Croatian: Gallagher et al (2004.) ispitali su djelovanje kalcitriola na padove u randomiziranom, dvostruko slijepom ispitivanju kontroliranom placebom u 489 postmenopauzanih žena s popunjenošću/viškom vitamina D, koje boluju od osteopenije.
English: The applicant has analysed pharmacokinetics data of alfacalcidol and calcitriol dosed independently from two bioequivalence studies.
Croatian: Podnositelj zahtjeva analizirao je farmakokinetičke podatke alfakalcidola i kalcitriola koji su dozirani nezavisno od dva ispitivanja bioekvivalentnosti.
English: Ringe et al (2007) presented a randomised trial, where three treatments were compared ‘alfacalcidol alone', ‘alfacalcidol + alendronate' and ‘alendronate + vitamin D + calcium'.
Croatian: Ringe et al (2007.) predstavio je randomizirano ispitivanje, u kojem su uspoređena tri liječenja; i to „monoterapija alfakalcidolom”, „alfakalcidol + alendronat” i „alendronat + vitamin D + kalcij”.
English: The results over 36 weeks showed that alfacalcidol treatment was associated with fewer non-significantly fallers than placebo (OR (Odds ratio) 0.69, 95% CI (confidence interval): 0.41-1.16).
Croatian: Rezultati prikupljeni tijekom 36 tjedana pokazali su da je liječenje alfakalcidolom povezano s manje osoba s neznačajnim padom u odnosu na placebo (OR (omjer izgleda) 0,69, 95% CI (interval pouzdanosti): 0,41-1,16).
English: Alendronic acid is a bisphosphonate with high affinity for the hydroxylapatite of the bone.
Croatian: Alendronatna kiselina je bisfosfonat s visoki afinitetom za hidroksilapatit kosti.
English: Higher performance in functional tests is associated with a significantlylower number of fallers and risk of falls, therefore the positive effects of alfacalcidol treatment on physical performance should be considered for the assessment of the results of alfacalcidol in the reduction of falls in elderly and in patients with PMO.
Croatian: Visoka učinkovitost u funkcionalnim testovima povezana je sa značajno manjim brojem osoba koje su pale i rizikom od padova, stoga se pozitivni učinci liječenja alfakalcidolom na fizičku učinkovitost trebaju uzeti u razmatranje pri ocjeni rezultata alfakalcidola u smanjenju padova u starijih osoba i u bolesnika koji boluju od PMO-a.
English: Treatment with calcitriol 0.25 μg twice daily significantly reduced the number of fallers (OR 0.54 (95% CI 0.31-0.94, p<0.03) and decreased the incidence of falls compared to placebo (0.27 versus 0.43, p=0.0015) in this 3 years trial.
Croatian: Liječenje dozom kalcitriola od 0,25 μg dva puta dnevno značajno je smanjilo broj osoba koje su padale (OR 0,54 (95% CI 0,31-0,94, p<0,03) te je smanjio incidenciju padova u usporedbi s placebom (0,27 u odnosu na 0,43, p=0,0015) u ovom trogodišnjem ispitivanju.
English: Furthermore, the applicant claimed that these results on alfacalcidol monotherapy have been confirmed in a post-approval trial of the combination package of 70 mg alendronate weekly and 1 μg
Croatian: Nadalje, podnositelj zahtjeva tvrdio je da su ovi rezultati monoterapije alfakalcidolom potvrđeni uispitivanjima provedenima nakon izdavanja odobrenja za stavljanje lijeka u promet za kombinirani paket od 70 mg alendronata tjedno i 1 μg alfakalcidola dnevno (Tevabone).
English: Alfacalcidol alone was slightly superior to alendronate + plain Vitamin D + calcium after two years (MW = 0.5422; CI-LB = 0.4838; p = 0.0785).
Croatian: Monoterapija alfakalcidolom bila je neznatno superiornija u odnosu na terapiju alendronatom + običnim vitaminom D + kalcijem nakon dvije godine (MW = 0,5422; CI-LB = 0,4838; p = 0,0785).
English: The applicant also provided a population modelling and simulation of results to demonstrate that there is no difference between alfacalcidol and calcitriol treatments at appropriate and equivalent dosing.
Croatian: Podnositelj zahtjeva također je dostavio modeliranje populacije i simulaciju rezultata kako bi dokazao da nema razlike između liječenja alfakalcidolom i kalcitriolom u odgovarajućoj i ekvivalentnoj dozi.
English: The CHMP agreed to provide the respective information in section 5.1 of the Summary of the Product Characteristics and section 1 of the package leaflet.
Croatian: CHMP je pristao dostaviti odgovarajuću informaciju u dijelu 5.1 Sažetka opisa svojstava lijeka i dijelu 1.
English: The analysis has demonstrated that there is no difference in calcitriol exposure at steady state after administration of either alfacalcidol or calcitriol at appropriate and equivalent dosing.
Croatian: Analiza je pokazala da nema razlike u izlaganju kalcitriolu u stabilnom stanju nakon primjene alfakalcidola ili kalcitriola u odgovarajućem i ekvivalentnom doziranju.
English: In order to demonstrate the role of alfacalcidol in the reduction of falls, the applicant made reference to published clinical studies which support the effect of alfacalcidol alone and in combination with alendronic acid on the improvement of physical performance, the incidence of non-vertebral fractures and on falls.
Croatian: Kako bi se dokazala uloga alfakalcidola u smanjivanju broja padova, podnositelj zahtjeva referirao je na objavljena klinička ispitivanja koja podržavaju djelovanje alfakalcidola kao monoterapije te u kombinaciji s alendronatnom kiselinom o poboljšanoj fizičkoj učinkovitosti, incidenciji nevertebralnih prijeloma i o padovima.
English: The combination ‘alendronate + alfacalcidol' showed a significant superiority in reduction of falls compared to ‘alendronate + plain Vitamin D + calcium' after two years (MannWhitney (MW) = 0.5506; Confidence interval Lower bound (CI-LB) = 0.4937; p=0.0407) but not superiority to ‘alfacalcidol alone'.
Croatian: Kombinacija „alendronat + alfakalcidol” pokazala je značajnu superiornost u smanjenju broja padova u usporedbi s „alendronatom + običnim vitaminom D + kalcijem” nakon dvije godine (Mann-Whitney (MW) = 0,5506; donja granica intervala pouzdanosti(CI-LB) = 0,4937; p=0,0407), no ne i superiornost u odnosu na „monoterapiju alfakalcidolom”.
English: Significant fall reduction in alfacalcidol-treated subject with a total calcium intake of more than 512 mg/d (median Ca intake in the study) (OR 0.45; 95% CI 0.21-0.97, p=0.042) was observed but not in those with less Ca intake than 512 mg/d (OR 1.00, 95% CI 0.47-2.11, p=0.998).
Croatian: Uočeno je značajno smanjenje pada u subjekata liječenih alfakalcidolom s ukupnim unosom kalcija većim od 512 mg/d (medijan unosa Ca u ispitivanju) (OR 0,45; 95% CI 0,210,97, p=0,042), no ne u onih osoba s unosom Ca manjim od 512 mg/d (OR 1,00, 95% CI 0,47-2,11, p=0,998).
English: 10 Ringe JD, Farahmand P, Schacht E. Alfacalcidol in men with osteoporosis: a prospective, observational, 2-year trial on
Croatian: Alfacalcidol in men with osteoporosis: a prospective, observational, 2-year trial on
English: Richy F, Dukas L, Schacht E. Differential effects of D-hormone analogs and native Vitamin D on the risk of falls: A comparative meta-analysis.
Croatian: Differential effects of D-hormone analogs and native Vitamin D on the risk of falls: A comparative meta-analysis.
English: Studies on reduction of falls and fall-related non-vertebral fractures
Croatian: Ispitivanja smanjenja broja padova i nevertebralnih prijeloma povezanih s padovima
English: The analysis was done using population pharmacokinetic modelling to confirm the exchangeability of alfacalcidol and calcitriol when administrated at appropriately scaled doses.
Croatian: Analiza je provedena primjenom populacijskog farmakokinetičkog modeliranja kako bi se potvrdila zamjenjivost alfakalcidola i kalcitriola prilikom primjene u odgovarajućim određenim dozama.
English: The applicant further performed a meta-analysis of trials with alfacalcidol and calcitriol investigating fallers.
Croatian: Nadalje, podnositelj zahtjeva proveo je meta analizu ispitivanja s alfakalcidolom i kalcitriolom istražujući osobe koje su padale.
English: O'Donnell S, Moher D, Thomas K, Hanley D A, Cranney A. Systematic review of the benefits and harms of calcitriol and alfacalcidol for fractures and falls.
Croatian: O'Donnell S, Moher D, Thomas K, Hanley D A, Cranney A.
English: In addition, 500 mg of calcium daily was added in each arm. Amongst other parameters the authors compared the rate of falls between the three groups.
Croatian: Nadalje, 500 mg kalcija dnevno dodano je u svaku ruku.